Skip to main content

Friedman Paul A

In the past year, 3 open-market sale filings worth $26.7M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$26.7M
3 filings
Net
−$26.7M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Friedman Paul A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MDGL Madrigal Pharmaceuticals, Inc.

Director9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 13, 2026 (view filing)Jan 94 daysFriedman Paul ADirectorSSale−280$551.24−$154.3K−0.1%187.2K after10b5-1
Jan 13, 2026 (view filing)Jan 94 daysFriedman Paul ADirectorSSale−24.5K$522.39−$12.8M−11.6%187.2K after28 lots10b5-1
Dec 12, 2025 (view filing)Dec 102 daysFriedman Paul ADirectorSSale−24.8K$552.18−$13.7M−11.7%187.2K after9 lots10b5-1
Aug 13, 2025 (view filing)Aug 13Same dayFriedman Paul ADirectorSSale−129.2K$370.24−$47.8M−40.8%187.2K after17 lots10b5-1
Aug 13, 2025 (view filing)Aug 11-122 daysFriedman Paul ADirectorSSale−46.8K$355.31−$16.6M−20.0%187.2K after12 lots10b5-1
Jul 22, 2025 (view filing)Jul 184 daysFriedman Paul ADirectorSSale−1.40K$350.03−$490.0K−0.7%187.2K after10b5-1
Jul 18, 2025 (view filing)Jul 16-172 daysFriedman Paul ADirectorSSale−28.9K$353.19−$10.2M−13.4%187.2K after9 lots10b5-1
Apr 10, 2024 (view filing)Apr 82 daysFriedman Paul ADirectorSSale−26.3K$246.19−$6.47M−12.4%185.7K after7 lots10b5-1
Apr 5, 2024 (view filing)Apr 3-52 daysFriedman Paul ADirectorSSale−73.7K$243.93−$18.0M−28.4%185.7K after20 lots10b5-1